FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells-Reference-Cited by-同舟云学术

FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells

Published:2017-10 Issue:10 Volume:19 Page:791-804
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Turczyk Lukasz,Kitowska Kamila,Mieszkowska Magdalena,Mieczkowski Kamil,Czaplinska Dominika,Piasecka Dominika,Kordek Radzisław,Skladanowski Andrzej C.,Potemski Piotr,Romanska Hanna M.,Sadej Rafal

Publisher

Elsevier BV

Subject

Cancer Research

Reference64 articles.

1. Gene expression profiling in breast cancer: classification, prognostication, and prediction;Reis-Filho;Lancet,2011

2. Biological subtypes of breast cancer: Prognostic and therapeutic implications;Yersal;World J Clin Oncol,2014

3. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling;Clarke;Oncogene,2003

4. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Davies;Lancet,2011

5. Liganded and unliganded activation of estrogen receptor and hormone replacement therapies;Maggi;Biochim Biophys Acta,2011

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Pathology with Artificial Intelligence: Innovations in Immunohistochemistry;Journal of Personalized Medicine;2024-06-27

2. FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs;Cellular & Molecular Biology Letters;2024-05-14

3. FGFR4-driven plasticity in breast cancer progression and resistance to therapy;British Journal of Cancer;2024-04-17

4. Is fibroblast growth factor 11 (FGF11) a predictive marker for breast cancer?;Medicine;2024-03-29

5. Estrogen regulation and functional role of FGFR4 in estrogen receptor positive breast cancer;2024-03-20